מסכים גנטיים
View the full transcript and gain access to JoVE Science Education videos
Q1: What is the difference between forward and reverse genetic screens?
Forward genetic screens randomly generate mutations in an organism's DNA using mutagens or transposons, then identify unknown genes responsible for phenotypes of interest. Reverse genetic screens take the opposite approach: researchers target specific candidate genes for disruption, then observe resulting mutant phenotypes. Both methods help uncover gene function and biological pathways.
Q2: How do loss-of-function and gain-of-function mutations differ in genetic screens?
Loss-of-function mutations disrupt a gene's activity, reducing its expression or function. Gain-of-function mutations increase a gene's expression or functionality, often by inserting regulatory elements that drive overexpression. Expression screening uses plasmid libraries containing protein-coding sequences to achieve gain-of-function effects and understand gene function.
Q3: What are suppressor and enhancer screens used for?
Suppressor screens identify mutations that reduce the severity of an existing mutant phenotype, revealing genes that interact or compensate for the original mutation. Enhancer screens find mutations that increase phenotype severity, helping determine redundant or functionally interacting genes. Synthetic lethality screens reveal genes in essential but redundant pathways, useful for identifying drug targets in cancer therapy.
Q4: How is chemical mutagenesis performed in nematode worms?
In forward screens using nematodes, worms at the last larval stage are exposed to ethyl methanesulfonate (EMS), a chemical mutagen that modifies guanine nucleotides, causing mispairing with thymine during DNA replication. After several hours of incubation, EMS is removed and inactivated with sodium hydroxide. Worms are then washed, plated on agar with bacterial food, and allowed to reproduce for screening.
Q5: What is the protocol for reverse genetic screening in nematodes?
Reverse screens in nematodes use bacterial libraries expressing double-stranded RNA targeting individual candidate genes. Bacteria are cultured, spotted onto plates with nematode growth medium, and allowed to dry. Worms feed on the bacteria for three to four days in a humidified chamber, and mutant phenotypes are observed in original worms or first-generation progeny.
Q6: How are genetic screens applied to identify protein interactions and drug targets?
Researchers use high-throughput microscopy-based screens to discover receptors affecting signaling protein localization by overexpressing genes in cultured cells. For drug interactions, mutant libraries are grown with drugs, and growth is quantified using detection and quantification of nucleic acids by real time PCR followed by microarray or sequencing analysis to identify drug-sensitive strains.
Q7: How can genetic screens help understand genes involved in neurodegenerative diseases?
Researchers culture neurons in the presence of RNA-encoding viruses to knock down expression of many target genes. Automated analysis of immunostained cells reveals genes influencing neuronal properties like neurite outgrowth. This approach has successfully identified genes involved in neurodegenerative diseases, demonstrating how screens uncover molecular networks disrupted in human disease.